Neogen Corporation (NEOG)
Summary
Neogen Corporation: Promising Recurring Demand With Food Safety
I believe Neogen's recurring food safety products provide a foundation for its operating recovery. However, management has to execute carefully and proceed with the Petrifilm transition, which, if successful, should improve its cash flows long-term. Also, NEOG's recent genomics sale should give it extra flexibility, but we have to wait and see until we know how much its earnings may decrease as a result.
Neogen Investor Day Sets Path for Growth, 30% EBITDA Margin by 2031
Neogen NASDAQ: NEOG outlined a multi-year strategy at its first Investor Day, emphasizing a shift from business stabilization toward accelerated growth, higher margins and stronger cash generation. Management said the company has delivered positive core growth for four consecutive quarters and is targeting high-single-digit to low-double-digit long-term revenue growth, adjusted gross margins in the high-50% range, adjusted EBITDA margins of approximately 30% and free-cash-flow conversion of about 80% by fiscal 2031.
Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended August 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Neogen Corporation Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 756 | $10,561.32 | $8,864.1 | -$1,697.22 | -16.07% |
 Curtis Ellergodt Rothschild Investment LLC | 566 | $3,887.95 | $6,865.58 | $2,977.63 | 76.59% |
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 22,693 | $204,007 | $275,266.09 | $71,259.09 | 34.93% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 278 | $2,582.62 | $3,372.14 | $789.52 | 30.57% |
| NA Nizar Araji National Bank Of Canada /FI/ | 4M | $33.48M | $49.08M | $15.6M | 46.57% |
Neogen Corporation Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| SN Subbu Nambi Guggenheim | 1,637.02 | $20,953.83 | $19,357.74 | -$1,596.09 | -7.62% |
Neogen Corporation (NEOG) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Neogen Corporation ever had a stock split?
Neogen Corporation Profile
| Professional Services Industry | Industrials Sector | Mikhael Nassif CEO | NASDAQ (NGS) Exchange | 640491106 CUSIP |
| US Country | 2,636 Employees | - Last Dividend | 7 Jun 2021 Last Split | 23 Aug 1989 IPO Date |
Overview
Neogen Corporation is a global company that specializes in developing, manufacturing, and marketing a plethora of products and services designed for food and animal safety. With its operations divided into two main segments, Food Safety and Animal Safety, Neogen Corporation serves a wide range of markets worldwide. Its efforts are directed towards ensuring the detection of dangerous and unintended substances in food and feed, as well as providing solutions for animal health and safety. Founded in 1981, Neogen has its headquarters in Lansing, Michigan, from where it coordinates its worldwide operations, consistently working towards improving food and animal safety standards globally.
Products and Services
Neogen Corporation’s offerings span across various products and services geared towards ensuring food and animal safety through two primary segments:
- Food Safety: This segment focuses on the provision of:
- Diagnostic test kits and related products to detect foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns.
- AccuPoint Advanced, a rapid sanitation test for adenosine triphosphate (ATP) detection, indicating the presence of living cells.
- Genomics-based diagnostic technology and software systems for objective analysis and storage of test results, enabling analysis of results from multiple locations over extended periods.
- Animal Safety: In this segment, Neogen offers:
- Veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services.
- These products and services are marketed towards companion animal veterinarians, livestock producers, veterinarians, breed associations, retailers, breeding and genetics companies, diagnostic labs, universities, distributors, other manufacturers, and government agencies.
Contact Information
